Should adults with suspected bacterial meningitis receive adjunctive dexamethasone?
Diederik van de Beek* and Jan de Gans
Correspondence *Department of Neurology, Center of Infection and Immunity Amsterdam, University of Amsterdam, Academic Medical Center, Amsterdam, The Netherlands
Email d.vandebeek@amc.uva.nl
This article has no abstract so we have provided the first paragraph of the full text.
The urgent diagnosis and treatment of bacterial meningitis is challenging, and severe disability or death can ensue even with appropriate antibiotic treatment. Studies in animals have shown that adjuvant treatment with anti-inflammatory agents, such as dexamethasone, reduces both cerebrospinal fluid inflammation and neurological sequelae.1
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.